A/Prof Catherine Mitchell
Clinical (Associate Professor)
The Sir Peter MacCallum Department of Oncology
151 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in Australia
DOI: 10.1111/ajco.700432026
Journal article
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.
DOI: 10.1038/s41467-026-74334-z2026
Journal article
Diagnosis and treatment of primary soft tissue sarcomas: comprehensive review
DOI: 10.1093/bjsopen/zraf1772026
Journal article
Pathologic Assessment of Retroperitoneal Sarcomas
DOI: 10.1097/PAS.00000000000025002026
Journal article
P0350 Biochemical recurrence and safety in patients with high-risk localised prostate cancer treated with [177Lu] Lu-PSMA-617 prior to prostatectomy: Follow-up of the LuTectomy trial
DOI: 10.1016/s0302-2838(26)01246-72026
Journal article
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory
DOI: 10.1007/s40291-025-00820-72018
Journal article
Cold kit for prostate-Specific membrane antigen (PSMA) PET imaging: Phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
DOI: 10.2967/jnumed.117.199554
RECENT SCHOLARLY WORKS
2026
Journal article
Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies
DOI: 10.1177/175883592614218102025
Journal article
Paraganglioma: An Important Differential for Retroperitoneal Masses
DOI: 10.1111/ans.702542025
Journal article
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin
DOI: 10.1186/s12885-025-13506-42025
Journal article
Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy
DOI: 10.3390/jimaging11120450